SCHEMBL5169319

SCHEMBL5169319

O=C(O)C1(I)CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
LMNA P02545 3/20 0.47
HTT P42858 1/20 0.47
CNR1 P21554 1/20 0.47
GAA P10253 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.43
POLB P06746 2/20 0.43
HPGD P15428 1/20 0.43
PKM P14618 1/20 0.42
PKLR P30613 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CACNA1B Q00975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5170741 0.85 MEN1 (0.46) KMT2AMEN1LMNASMN1; SMN2POLB
SCHEMBL5171066 0.85 MEN1 (0.46) KMT2AMEN1LMNASMN1; SMN2POLB
SCHEMBL5173406 0.80 L3MBTL1 (0.47) LMNAHTTGAAPKMPKLR
SCHEMBL13570986 0.79 KMT2A (0.50) KMT2AMEN1LMNAGAASMN1; SMN2
SCHEMBL27370216 0.73 HTT (0.70) KMT2AMEN1LMNAHTTCNR1
SCHEMBL14625303 0.72 HTT (0.68) KMT2AMEN1LMNAHTTCNR1
SCHEMBL29944227 0.72 HTT (0.68) KMT2AMEN1LMNAHTTCNR1
SCHEMBL629731 0.71 POLB (0.62) LMNAHTTCNR1POLBALDH1A1
SCHEMBL629730 0.71 POLB (0.62) LMNAHTTCNR1POLBALDH1A1
SCHEMBL15100910 0.69 LMNA (0.74) LMNAHTTCNR1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP claimed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO claimed
EP-1778637-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF Aventis Pharmaceuticals, Inc. (US) 2007-05-02 EP disclosed
WO-2006012256-A2 FKBP BINDING COMPOSITION AND PHARMACEUTICAL USE THEREOF AVENTIS PHARMACEUTICALS INC. (US) 2006-02-02 WO disclosed